Skip to main content
Premium Trial:

Request an Annual Quote

Genialis ResponderID

Genialis has launched ResponderID, an artificial intelligence/machine learning-enabled platform for use in clinical biomarker discovery. ResponderID defines, models, and validates new biomarkers for drug development and discovery programs. The platform is a technology suite for clinical and translational research that incorporates proprietary tools for feature selection, data harmonization, and machine learning modeling. While ResponderID can complement virtually any data-analysis environment, it is typically powered by data from Genialis Expressions, the company's FAIR-inspired data management and bioinformatics processing software suite.